Docstoc

Aarkstore.com 2012 15% Discount ||

Document Sample
Aarkstore.com 2012 15% Discount || Powered By Docstoc
					Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Pricing and Reimbursement of the Healthcare System in India -
Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket
Expenditure


http://www.aarkstore.com/reports/Pricing-and-Reimbursement-of-the-
Healthcare-System-in-India-Low-Levels-of-Drug-Reimbursement-Lead-to-a-
High-Out-Of-Pocket-Expenditure-194956.html




RSS Link of GBI Research

Company announces 15% discount on this report.

Discount till 30th June 2012



Summary

Company, the leading business intelligence provider, has released its latest research
Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug
Reimbursement Lead to a High Out-Of-Pocket Expenditure”. It provides a
comprehensive overview of the healthcare system, and pricing and reimbursement
process in India with a detailed analysis of the different regulatory mechanisms
used in India. The report closely scrutinizes the major changes in pharmaceuticals
related pricing and reimbursement in the recent past, and the impact these changes
will have in the future. The health insurance is responsible for facilitating demand
by making high-cost prescription drugs more affordable. Although the per capita
income is rising in India, the modest income of most of the population keeps the
high cost drugs and medicines out of reach of the majority of the population.


Scope

- Detailed study of the healthcare systems and roles of the key insurance players in
the drug reimbursement process
- Analysis of the major pricing and reimbursement mechanisms in India.
- Key trends that follow from the recent changes brought about in the pricing and
reimbursement mechanism.
- Build an understanding of the possible major challenges brought about by the
enactment of changes in the pricing and reimbursement scene in India.

Table of contents:

1.1 List of Tables 5
1.2 List of Figures 5
2 Pricing and Reimbursement in India - Introduction 6
2.1 GBI Research Report Guidance 6
3 Pricing and Reimbursement in India - Overview 7
3.1 Introduction to Healthcare System in India 7
3.1.1 Healthcare Expenditure Highly Correlated with GDP 7
3.1.2 Estimated Public Health Spending as a Percentage of GDP 9
3.1.3 Health Expenditure per Capita 9
3.1.4 Out-of-Pocket Health Expenditure as a Percentage of Private Expenditure on
Health 10
3.1.5 Demographics by Age 10
3.2 Public Healthcare System 11
3.2.1 Drug Distribution in the Public Sector 12
3.3 Private Healthcare System 12
3.4 Rationale for Drug Use in the Healthcare Facilities 13
4 Pricing and Reimbursement in India- Overview of Pharmaceutical Regulations in
India 14
4.1 PEST Analysis of the Pharmaceutical Industry in India 14
4.2 Regulatory Bodies in the Indian Pharmaceutical Sector 15
4.2.1 National Pharmaceutical Pricing Authority (NPPA) 15
4.2.2 Drug Prices Control Order (DPCO) 16
4.2.3 The Pharmaceutical Policy, 2002 16
5 Pricing and Reimbursement in India- Pricing of Drugs 17


List of Figures

List of Tables are also include.
For more DISCOUNT related Reports Plz follow The link:

Diabetes Therapeutics Market to 2017 - Better Glycemic Control and Reduced
Potential Risk of Hypoglycemia to Increase the Market Share of DPP-IV Inhibitors
and GLP-1 Agonists

Emerging Pharmaceutical Market - Czech Republic - Planned Healthcare Reform
Plans Forecast to Slow Growth Rates

Endocrinology Market to 2018 - Advanced Injection Devices for Growth Hormone
and Somatostatin will Improve Ease of Use for Patients

Pediatric Vaccines Market to 2017- Strategic Focus on Partnering as Licensing and
Co-Development Accounted for 69% of Deal-Making Activity from 2004-2011

Regulatory Intelligence on Biologics Recalls – Immunoglobulins and Vaccines are
Involved in More Recalls than Other Drug Classes

Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as
Diovan, Micardis, Avapro and Atacand to Accelerate Erosion

Neurometabolic Disorders Market to 2017 - Novel Therapies for Rare Diseases such
as Gaucher’s and Niemann-Pick Poised to Supersede Existing Therapies

Urological Disorders Therapeutics to 2017 - Large Number of Licensing Deals for
Approved Products Reflects a Pessimistic R&D Future

Transcatheter Heart Valve Market to 2017 - Improvements in Design and Technique
and a Favorable Reimbursement Scenario to Contribute to Higher Procedure
Volumes

Smart Grid Market in Europe to 2020 - Advanced Grid Concepts and Intelligent
Technology Pivotal to Achieving EU 20-20-20 Targets
Oil and Gas Storage Industry to 2015 - Cost Reduction Strategies in the Form of
Storage Facility Sharing to Boost the Market




You can also request for sample page of above mention reports on
sample@aarkstore.com




For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:0
posted:6/27/2012
language:
pages:4
Description: Company, the leading business intelligence provider, has released its latest research Pricing and Reimbursement of the Healthcare System in India - Low Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure”.